These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25832910)

  • 1. Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies.
    Anitua E; Muruzabal F; Tayebba A; Riestra A; Perez VL; Merayo-Lloves J; Orive G
    Acta Ophthalmol; 2015 Dec; 93(8):e605-14. PubMed ID: 25832910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases.
    Anitua E; Muruzabal F; de la Fuente M; Merayo J; Durán J; Orive G
    Curr Eye Res; 2016 Jul; 41(7):875-82. PubMed ID: 26828610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of "eye platelet rich plasma" (E-PRP) for wound healing in ophthalmology.
    Alio JL; Arnalich-Montiel F; Rodriguez AE
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1257-65. PubMed ID: 21740369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts.
    Anitua E; de la Fuente M; Muruzabal F; Riestra A; Merayo-Lloves J; Orive G
    Exp Eye Res; 2015 Jun; 135():118-26. PubMed ID: 25708868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood derived eye drops for the treatment of cornea and ocular surface diseases.
    Giannaccare G; Versura P; Buzzi M; Primavera L; Pellegrini M; Campos EC
    Transfus Apher Sci; 2017 Aug; 56(4):595-604. PubMed ID: 28844373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop.
    Anitua E; Muruzabal F; De la Fuente M; Merayo-Lloves J; Orive G
    Exp Eye Res; 2014 Feb; 119():27-34. PubMed ID: 24345372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and prospects of platelet-rich plasma therapy in veterinary ophthalmology.
    Sharun K; Chandran D; Manjusha KM; Mankuzhy PD; Kumar R; Pawde AM; Dhama K; El-Husseiny HM; Amarpal
    Vet Res Commun; 2023 Sep; 47(3):1031-1045. PubMed ID: 36607500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 Months.
    Anitua E; Muruzabal F; Pino A; Merayo-Lloves J; Orive G
    Cornea; 2013 Oct; 32(10):1380-6. PubMed ID: 23974892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet rich plasma in ocular surface.
    Riestra AC; Alonso-Herreros JM; Merayo-Lloves J
    Arch Soc Esp Oftalmol; 2016 Oct; 91(10):475-90. PubMed ID: 27062018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops After Their Different Time and Temperature Conditions of Storage.
    Anitua E; de la Fuente M; Riestra A; Merayo-Lloves J; Muruzábal F; Orive G
    Cornea; 2015 Sep; 34(9):1144-8. PubMed ID: 26165790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells.
    Anitua E; de la Fuente M; Sánchez-Ávila RM; de la Sen-Corcuera B; Merayo-Lloves J; Muruzábal F
    Curr Eye Res; 2023 May; 48(5):456-464. PubMed ID: 36695530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model.
    Anitua E; Muruzabal F; de la Fuente M; Riestra A; Merayo-Lloves J; Orive G
    Exp Eye Res; 2016 Oct; 151():115-21. PubMed ID: 27567559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus.
    Anitua E; de la Sen-Corcuera B; Orive G; Sánchez-Ávila RM; Heredia P; Muruzabal F; Merayo-Lloves J
    Expert Opin Biol Ther; 2022 Jan; 22(1):31-45. PubMed ID: 34275392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of Modified Autologous Conditioned Serum and Ex Vivo Assessment of Its Healing Potential in Murine Corneal Epithelium.
    Hsiung C; Liu YT; Su CY; Hsiung CC; Hung KH; Yeh LK
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 37036242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-derived topical therapy for ocular surface diseases.
    Soni NG; Jeng BH
    Br J Ophthalmol; 2016 Jan; 100(1):22-7. PubMed ID: 26178904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye platelet-rich plasma in the treatment of ocular surface disorders.
    Alio JL; Rodriguez AE; WróbelDudzińska D
    Curr Opin Ophthalmol; 2015 Jul; 26(4):325-32. PubMed ID: 26058033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-Derived Eye Drops for the Treatment of Corneal Neuropathic Pain.
    Anam A; Liu C; Tong L; Liu YC
    J Ocul Pharmacol Ther; 2024 Jun; 40(5):281-292. PubMed ID: 38648544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical considerations in the use of platelet-rich plasma.
    Toscano N; Holtzclaw D
    Compend Contin Educ Dent; 2008 Apr; 29(3):182-5. PubMed ID: 18468304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-Induced myodifferentiation.
    Anitua E; Sanchez M; Merayo-Lloves J; De la Fuente M; Muruzabal F; Orive G
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6066-73. PubMed ID: 21613374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet derivatives in regenerative medicine: an update.
    De Pascale MR; Sommese L; Casamassimi A; Napoli C
    Transfus Med Rev; 2015 Jan; 29(1):52-61. PubMed ID: 25544600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.